Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Chunghwa Telecom Co Ltd ADR

Start price
Target price
Perf. (%)
€36.40
24.06.23
-
24.06.24
-1.10%
25.06.24

Magnachip Semiconductor

Start price
Target price
Perf. (%)
€9.85
24.06.23
-
24.06.24
-54.31%
25.06.24

buy
Prestige Consumer Healthcare Inc.

Start price
Target price
Perf. (%)
€52.50
24.06.23
-
24.06.24
20.95%
25.06.24

buy
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€0.47
24.06.23
-
24.06.24
-
25.06.24

buy
Fiserv Inc.

Start price
Target price
Perf. (%)
€111.10
24.06.23
-
24.06.24
26.08%
25.06.24

buy
Gaia Inc. A

Start price
Target price
Perf. (%)
€2.20
24.06.23
-
24.06.24
91.82%
25.06.24

Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.27
24.06.23
-
24.06.24
-0.75%
25.06.24

T2 Biosystems Inc.

Start price
Target price
Perf. (%)
€0.066
24.06.23
-
24.06.24
148.41%
25.06.24

Exelon Corp.

Start price
Target price
Perf. (%)
€36.64
24.06.23
-
24.06.24
-8.77%
25.06.24

Oragenics Inc.

Start price
Target price
Perf. (%)
€7.60
24.06.23
-
24.06.24
0.00%
25.06.24

International Tower Hill M.

Start price
Target price
Perf. (%)
€0.42
24.06.23
-
24.06.24
9.07%
25.06.24

Spirit Airlines, Inc.

Start price
Target price
Perf. (%)
€14.85
24.06.23
-
24.06.24
-77.63%
25.06.24

Roku

Start price
Target price
Perf. (%)
€57.06
24.06.23
€53.00
24.06.24
20.28%
14.07.23

Known brand
Normal challenges to pay loans and raise capital
Capable Management
Significant cyclical dependencies
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€0.52
24.06.23
€0.30
24.06.24
2.32%
11.09.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€0.64
24.06.23
€1.60
24.06.24
-5.78%
25.06.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Teladoc Health Inc

Start price
Target price
Perf. (%)
€21.48
24.06.23
€19.00
24.06.24
6.52%
14.07.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Arista Networks

Start price
Target price
Perf. (%)
€137.25
24.06.23
€128.00
24.06.24
22.77%
26.08.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€265.00
24.06.23
€270.00
24.06.24
3.96%
17.07.23

Top 10 in its market
Revenue growth >5% per year expected
Good rating
Some uniques
Exasol AG

Start price
Target price
Perf. (%)
€3.20
24.06.23
€2.00
24.06.24
-0.78%
14.07.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Low dividend yield expected
Medigene AG

Start price
Target price
Perf. (%)
€1.87
24.06.23
€1.00
24.06.24
-36.73%
25.06.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Upstart Holdings Inc.

Start price
Target price
Perf. (%)
€27.47
24.06.23
€22.00
24.06.24
52.83%
14.07.23

Good rating
Good culture
Few uniques
Low dividend yield expected
buy
Salesforce.com

Start price
Target price
Perf. (%)
€192.40
24.06.23
€269.00
24.06.24
16.42%
25.06.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€90.32
24.06.23
€128.00
24.06.24
33.30%
25.06.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Low dividend yield expected
buy
Ascendis Ph.sp.adr 1 Dk 1

Start price
Target price
Perf. (%)
€79.00
24.06.23
€150.00
31.08.25
56.96%
14.08.24

Could be very worthwhile Investment >20% year
buy
Avita Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.00
24.06.23
€30.00
31.01.27
-27.86%
02.12.23

Could be very worthwhile Investment >20% year